REFACTO AF 500 UI INJ SRG
(Facteur VIII de coagulation recombinant Moroctocog Alfa) - Maladie rare sans désignation orpheline
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency) in adults and children of all ages, including newborns.
ReFacto AF is appropriate for use in adults and children of all ages, including newborns. ReFacto AF does not contain von Willebrand factor, and hence is not indicated in von Willebrand’s disease.